Wave Life Sciences (WVE) Revenue & Revenue Breakdown
Wave Life Sciences Revenue Highlights
Latest Revenue (Y)
$108.30M
Latest Revenue (Q)
$19.69M
Wave Life Sciences Revenue by Period
Wave Life Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $108.30M | -4.42% |
| 2023-12-31 | $113.31M | 3005.10% |
| 2022-12-31 | $3.65M | -91.09% |
| 2021-12-31 | $40.96M | 104.03% |
| 2020-12-31 | $20.08M | 25.61% |
| 2019-12-31 | $15.98M | 10.89% |
| 2018-12-31 | $14.41M | 289.15% |
| 2017-12-31 | $3.70M | 149.43% |
| 2016-12-31 | $1.49M | 876.97% |
| 2015-12-31 | $152.00K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Wave Life Sciences generated $108.30M in revenue during NA 2024, up -4.42% compared to the previous quarter, and up 677.61% compared to the same period a year ago.
Wave Life Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $19.69M | 57.06% |
| 2024-03-31 | $12.54M | -56.85% |
| 2023-12-31 | $29.06M | -40.96% |
| 2023-09-30 | $49.21M | 122.63% |
| 2023-06-30 | $22.11M | 70.98% |
| 2023-03-31 | $12.93M | 943.50% |
| 2022-12-31 | $1.24M | 334.74% |
| 2022-09-30 | $285.00K | -24.00% |
| 2022-06-30 | $375.00K | -78.57% |
| 2022-03-31 | $1.75M | -0.85% |
| 2021-12-31 | $1.76M | -95.15% |
| 2021-09-30 | $36.42M | 1212.07% |
| 2021-06-30 | $2.78M | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $9.44M | 173.59% |
| 2020-09-30 | $3.45M | 13.97% |
| 2020-06-30 | $3.03M | -27.25% |
| 2020-03-31 | $4.16M | 73.38% |
| 2019-12-31 | $2.40M | -18.06% |
| 2019-09-30 | $2.93M | -61.60% |
| 2019-06-30 | $7.63M | 152.08% |
| 2019-03-31 | $3.03M | -16.41% |
| 2018-12-31 | $3.62M | -19.43% |
| 2018-09-30 | $4.49M | -7.91% |
| 2018-06-30 | $4.88M | 243.11% |
| 2018-03-31 | $1.42M | -15.16% |
| 2017-12-31 | $1.68M | 147.93% |
| 2017-09-30 | $676.00K | - |
| 2017-06-30 | $676.00K | - |
| 2017-03-31 | $676.00K | - |
| 2016-12-31 | $676.00K | 72.45% |
| 2016-09-30 | $392.00K | -6.00% |
| 2016-06-30 | $417.00K | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $152.00K | 100.00% |
| 2015-09-30 | - | -100.00% |
| 2015-06-30 | $126.00K | 384.62% |
| 2015-03-31 | $26.00K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | - |
Wave Life Sciences generated $19.69M in revenue during Q2 2024, up 57.06% compared to the previous quarter, and up 152.31% compared to the same period a year ago.
Wave Life Sciences Revenue Breakdown
Wave Life Sciences Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 21 |
|---|---|
| Research Term | $18.50M |
Latest
Wave Life Sciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 21: Research Term (100.00%).
Wave Life Sciences Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 21 |
|---|---|
| Research Term | $18.50M |
Latest
Wave Life Sciences's latest quarterly revenue breakdown by geography, as of Jun 21: Research Term (100.00%).
Wave Life Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals | $2.25B | $420.15M |
| APLS | Apellis Pharmaceuticals | $709.95M | $176.57M |
| BPMC | Blueprint Medicines | $508.82M | $128.18M |
| CTMX | CytomX Therapeutics | $138.10M | $33.43M |
| DAWN | Day One Biopharmaceuticals | $131.16M | $20.07M |
| WVE | Wave Life Sciences | $108.30M | $19.69M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | $416.00K |
| ITOS | iTeos Therapeutics | $35.00M | $35.00M |
| PRQR | ProQR Therapeutics | $6.38M | $4.48M |
| ARWR | Arrowhead Pharmaceuticals | $3.55M | $2.50M |
| TCRX | TScan Therapeutics | $2.82M | - |
| XFOR | X4 Pharmaceuticals | $2.56M | $560.00K |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ASMB | Assembly Biosciences | - | $6.84M |
| MREO | Mereo BioPharma Group | - | - |